Searchable abstracts of presentations at key conferences in endocrinology

ea0016p85 | Bone and calcium | ECE2008

Clinical and hormonal variables to predict bone mineral density loss in anorexia nervosa patients

Gonzalez Amalia , Varsavsky Mariela , Fernandez Ines Luque , Leyva Socorro , Palma Moya Mercedes , Soto Marisa Fernandez

Objective: Anorexia nervosa (AN) is often associated with severe mineral bone loss and increased risk of fractures. The objective of this study was to assess the bone mineral density (BMD) in patients with AN and its relationship with different anthropometrics, clinical and hormonal parameters.Patients and methods: We evaluated 47 women with AN according to criteria of DSM-IV. The anthropometrics variables measured were: weight (kg) height (m), BMI (kg/m...

ea0014p560 | (1) | ECE2007

Differential expression of genes related to aggressiveness in non-functioning pituitary adenomas

Martinez-Brocca Maria Asuncion , Saez Carmen , Soto Alfonso , Castilla Carolina , Japon Miguel Angel

Prediction of the biological behavior in non-functioning pituitary adenomas (NFPA) according to morphological criteria is highly inaccurate. Reliable prognostic molecular markers could be useful in providing guidance in NFPA post-surgical follow-up.Aim: To identify differentially expressed genes between aggressive and non-aggressive NFPAs and to assess their prognostic value.Methods: Samples analyzed were selected from a series of ...

ea0081p133 | Endocrine-Related Cancer | ECE2022

Rapidly progressive cases of ectopic adrenocorticotropic hormone syndrome

Gonzalez Gracia Lucia , Lopez Gallardo Gema , Oulad Ahmed Bothayna , Dios Fuentes Elena , Beltran Romero Luis , Soto-Moreno Alfonso

Introduction: Adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome (CS) secondary to an ectopic source is an uncommon condition, accounting for 4-5% of all cases of CS and between 9-18% of cases of ACTH-dependent CS. Although numerous malignancies have been associated with ectopic ACTH syndrome (EAS), lung neuroendocrine tumours (NETs) are the most common. Refractory hypokalemia can be the presenting feature in EAS and is seen in up to 80% of cases. We present ...

ea0081ep264 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Association of adherence to the mediterranean diet and body composition in type 1 diabetes mellitus

Redondo Enrique , Del Carmen Andreo-Lopez Maria , Garcia Javier , Zarco Teresa , Bolivar Victoria Contreras , Luisa Fernandez Soto Maria

Introduction: Body composition is gaining great interest in some pathologies such as Type 1 Diabetes Mellitus (DM1). Adherence to the Mediterranean diet has been shown to be effective in improving the prognosis of cardiovascular disease, which is the main cause of mortality in these patients.Objectives: To assess whether adherence to the Mediterranean diet in DM1 is associated with improvement in disease control parameters, body composition, anthropometr...

ea0090p762 | Thyroid | ECE2023

Assesmement of An Artificial Intelligence-Based Decision Support System in The Thyroid Nodule Evaluation in Clinical Practice

Fernandez Velasco Pablo , Torres Torres Beatriz , Perez Lopez Paloma , Benito-Sendin Plaar Katia , De Luis Roman Daniel , Diaz Soto Gonzalo

Objective: To evaluate the impact of a decision support system (DSS) based on artificial intelligence (AI) -KoiosDS- on ultrasound (US) image analysis and risk stratification in thyroid nodules. Material and methods Retrospective US study of all thyroid nodules with histologic (AP) result from June 2020 to December 2021. Diagnostic performance of US with ACR-TIRADS, by four endocrinologists and DSS, before and after the use of AI was evaluated.Results: A...

ea0090ep794 | Pituitary and Neuroendocrinology | ECE2023

MAFLD prevalence in a cohort of patients with Cushing’s disease

Remon Pablo , Gutierrez Ana Pinar , Moreno Eva Venegas , Dios-Fuentes Elena , Gonzales David Cano , Romero-Gomez Manuel , Soto-Moreno Alfonso

Objectives: To describe the prevalence of liver steatosis in a cohort of patients with Cushing’s disease.Methods: Cross-sectional descriptive study. We included 59 patients with Cushing’s disease from our cohort of patients who underwent a Fibroscan to analyze the degree of hepatic steatosis (CAP measured in dB/m) and liver fibrosis (fibrosis measured in kPa). Biochemical algorithms of liver steatosis and fibrosis were assessed.<p class="ab...

ea0063p709 | Pituitary and Neuroendocrinology 2 | ECE2019

Protein expression of convertases involved in POMC processing in silent and functioning corticotroph tumors

Cano David , Garcia-Martinez Araceli , Flores Alvaro , Gil Joan , Puig-Domingo Manel , Webb Susan M , Soto Alfonso , Pico Antonio

Introduction: Previous results of our group, presented in the ECE last year, showed a lower gene expression of proconvertase PC1/3, involved in the processing of POMC, in silent corticotroph tumors (sCT) than in functioning ones (fCT), overall and in microadenomas. The aim of the present study was to quantify the protein expression of convertases involved in the processing of POMC (PC1/3) and in the degradation of ACTH (PC2, CPE and PAM) in a series of CT.</p...

ea0049ep603 | Diabetes therapy | ECE2017

Glycemic control and weight evolution in DM2 patients with canaglifozina

de Linares Lidia Urbon Lopez , Soto Cristina Crespo , Terroba Concepcion , Garrote Sara , Ventosa Marta , Marin Tomas , Cuellar Luis

In the late years ISGLT2 have became an usual choice to treat diabetes. The inhibition of the sodium-glucose co transporters (SLGT2) inhibits also the glucose reabsorption in the proximale tubule and increases the glucose excreted in the urine. Therefore hyperglycemia decreases and so does weight. This is a very convenient side effect since type 2 DM is highly associated with overweight/obesity. We show the results of HbA1c and weight evolution after starting canaglifozina 100...

ea0014p541 | (1) | ECE2007

Ketoconazole before transsphenoidal surgery in Cushing’s disease patiens as a good alternative to glucocorticoids perioperatory treatment

Venegas E , Soto A , Vazquez M , Guerrero R , Pumar A , Montero JM , Garcia N , Mangas MA , Leon A , Leal-Cerro A

Cushing’s disease is a debilitating endocrinopathy characterized by excessive cortisol levels in the blood which may be produced from tumours of the pituitary gland. The only way to achieve long term cure of Cushing’s disease is by Transphenoidal removal of the adenoma. ketoconazole, inhibit steroid (cortisol) production in the adrenal glands.The use of glucocorticids treatment before and after hypophisectomy is a classic management in the peri...

ea0014p542 | (1) | ECE2007

Analysis of three different tests in the diagnosis of growth hormone deficit (GHD) in patients with severe cerebral trauma

Soto A , Venegas E , Caro A , Gurrero R , Rincon MD , Garcia S , Pumar A , Leon A , Flores JM , Murillo F , Leal-Cerro A

Introduction: Patients with severe cerebral Trauma are a risk population for developing hipopituytarism. Diagnosis of GHD need to study pituitary gland reserve with a stimulation test. Insulin Tolerance test (ITT) is the best standard test, although has important contraindication in these patients and its realization is not always a possible. We evaluate the diagnostic capacity of two alternative test (Glucagon Test an GHRH-GHRP6 test) and compared them with ITT.<p class="...